Obesity correlates with the immunosuppressive ILC2s‐MDSCs axis in advanced breast cancer

Abstract Aim We investigated the relationship between the group 2 innate lymphoid cells (ILC2s)‐myeloid‐derived suppressor cells (MDSCs) axis and obesity‐related breast cancer. Methods Fifty‐eight patients with breast cancer who had first relapse and metastasis between January 2019 and August 2021 w...

Full description

Bibliographic Details
Main Authors: Wei Liu, Bingyu Li, Dan Liu, Bing Zhao, Gang Sun, Jianbing Ding
Format: Article
Language:English
Published: Wiley 2024-03-01
Series:Immunity, Inflammation and Disease
Subjects:
Online Access:https://doi.org/10.1002/iid3.1196
_version_ 1797242553931661312
author Wei Liu
Bingyu Li
Dan Liu
Bing Zhao
Gang Sun
Jianbing Ding
author_facet Wei Liu
Bingyu Li
Dan Liu
Bing Zhao
Gang Sun
Jianbing Ding
author_sort Wei Liu
collection DOAJ
description Abstract Aim We investigated the relationship between the group 2 innate lymphoid cells (ILC2s)‐myeloid‐derived suppressor cells (MDSCs) axis and obesity‐related breast cancer. Methods Fifty‐eight patients with breast cancer who had first relapse and metastasis between January 2019 and August 2021 were enrolled. The proportions of ILC2s and MDSCs in blood and the levels of cytokines in serum were detected with flow cytometry. Correlation analysis among clinical characteristics (such as body mass index [BMI]), cytokines, ILC2s, and MDSCs was conducted. Results There was a significant difference in the proportions of ILC2s and MDSCs between the high BMI group and the normal BMI group (p < .05). In the triple‐negative breast cancer (TNBC) patients, the proportions of ILC2s and MDSCs in the obese group were significantly higher than those in the nonobese group (p < .05). In all breast cancer patients, there was a positive correlation between BMI and the ILC2s‐MDSCs axis (p < .05). However, there was no correlation observed between the number of metastases, progression‐free survival, and the ILC2s‐MDSCs axis (p > .05). Additionally, ILC2s showed positive correlations with MDSCs, interleukin‐5 (IL‐5), IL‐10, IL‐17A, (PD‐L1), programmed cell death 2 ligand 2 (PD‐L2), and molecular typing (p < .05). Similarly, MDSCs exhibited positive correlations with IL‐5, IL‐8, IL‐9, IL‐17A, PD‐L1, and PD‐L2 (p < .05). In patients with TNBC, there was a positive correlation between BMI and IL‐5 (p < .05). Conclusion Conclusively, obesity may enhance the immunosuppressive effect of the ILC2‐MDSC axis in advanced breast cancer. IL‐5 may play a vital role in the ILC2‐MDSC axis and obesity in TNBC.
first_indexed 2024-04-24T18:41:04Z
format Article
id doaj.art-809c663d51734df6a276781a2771edfb
institution Directory Open Access Journal
issn 2050-4527
language English
last_indexed 2024-04-24T18:41:04Z
publishDate 2024-03-01
publisher Wiley
record_format Article
series Immunity, Inflammation and Disease
spelling doaj.art-809c663d51734df6a276781a2771edfb2024-03-27T12:16:38ZengWileyImmunity, Inflammation and Disease2050-45272024-03-01123n/an/a10.1002/iid3.1196Obesity correlates with the immunosuppressive ILC2s‐MDSCs axis in advanced breast cancerWei Liu0Bingyu Li1Dan Liu2Bing Zhao3Gang Sun4Jianbing Ding5School of Public Health Xinjiang Medical University Urumqi People's Republic of ChinaDepartment of Mammary Medicine Affiliated Tumor Hospital of Xinjiang Medical University Urumqi People's Republic of ChinaDepartment of Mammary Medicine Affiliated Tumor Hospital of Xinjiang Medical University Urumqi People's Republic of ChinaDepartment of Mammary Medicine Affiliated Tumor Hospital of Xinjiang Medical University Urumqi People's Republic of ChinaXinjiang Uygur Autonomous Region Cancer Center/Xinjiang Key Laboratory of Oncology Urumqi People's Republic of ChinaXinjiang Key Laboratory of Molecular Biology for Endemic Diseases Urumqi Xinjiang People's Republic of ChinaAbstract Aim We investigated the relationship between the group 2 innate lymphoid cells (ILC2s)‐myeloid‐derived suppressor cells (MDSCs) axis and obesity‐related breast cancer. Methods Fifty‐eight patients with breast cancer who had first relapse and metastasis between January 2019 and August 2021 were enrolled. The proportions of ILC2s and MDSCs in blood and the levels of cytokines in serum were detected with flow cytometry. Correlation analysis among clinical characteristics (such as body mass index [BMI]), cytokines, ILC2s, and MDSCs was conducted. Results There was a significant difference in the proportions of ILC2s and MDSCs between the high BMI group and the normal BMI group (p < .05). In the triple‐negative breast cancer (TNBC) patients, the proportions of ILC2s and MDSCs in the obese group were significantly higher than those in the nonobese group (p < .05). In all breast cancer patients, there was a positive correlation between BMI and the ILC2s‐MDSCs axis (p < .05). However, there was no correlation observed between the number of metastases, progression‐free survival, and the ILC2s‐MDSCs axis (p > .05). Additionally, ILC2s showed positive correlations with MDSCs, interleukin‐5 (IL‐5), IL‐10, IL‐17A, (PD‐L1), programmed cell death 2 ligand 2 (PD‐L2), and molecular typing (p < .05). Similarly, MDSCs exhibited positive correlations with IL‐5, IL‐8, IL‐9, IL‐17A, PD‐L1, and PD‐L2 (p < .05). In patients with TNBC, there was a positive correlation between BMI and IL‐5 (p < .05). Conclusion Conclusively, obesity may enhance the immunosuppressive effect of the ILC2‐MDSC axis in advanced breast cancer. IL‐5 may play a vital role in the ILC2‐MDSC axis and obesity in TNBC.https://doi.org/10.1002/iid3.1196advanced breast cancergroup 2 innate lymphoid cellsinflammatory factorsinterleukinmyeloid‐derived suppressor cellsobesity
spellingShingle Wei Liu
Bingyu Li
Dan Liu
Bing Zhao
Gang Sun
Jianbing Ding
Obesity correlates with the immunosuppressive ILC2s‐MDSCs axis in advanced breast cancer
Immunity, Inflammation and Disease
advanced breast cancer
group 2 innate lymphoid cells
inflammatory factors
interleukin
myeloid‐derived suppressor cells
obesity
title Obesity correlates with the immunosuppressive ILC2s‐MDSCs axis in advanced breast cancer
title_full Obesity correlates with the immunosuppressive ILC2s‐MDSCs axis in advanced breast cancer
title_fullStr Obesity correlates with the immunosuppressive ILC2s‐MDSCs axis in advanced breast cancer
title_full_unstemmed Obesity correlates with the immunosuppressive ILC2s‐MDSCs axis in advanced breast cancer
title_short Obesity correlates with the immunosuppressive ILC2s‐MDSCs axis in advanced breast cancer
title_sort obesity correlates with the immunosuppressive ilc2s mdscs axis in advanced breast cancer
topic advanced breast cancer
group 2 innate lymphoid cells
inflammatory factors
interleukin
myeloid‐derived suppressor cells
obesity
url https://doi.org/10.1002/iid3.1196
work_keys_str_mv AT weiliu obesitycorrelateswiththeimmunosuppressiveilc2smdscsaxisinadvancedbreastcancer
AT bingyuli obesitycorrelateswiththeimmunosuppressiveilc2smdscsaxisinadvancedbreastcancer
AT danliu obesitycorrelateswiththeimmunosuppressiveilc2smdscsaxisinadvancedbreastcancer
AT bingzhao obesitycorrelateswiththeimmunosuppressiveilc2smdscsaxisinadvancedbreastcancer
AT gangsun obesitycorrelateswiththeimmunosuppressiveilc2smdscsaxisinadvancedbreastcancer
AT jianbingding obesitycorrelateswiththeimmunosuppressiveilc2smdscsaxisinadvancedbreastcancer